Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
PRNewswire - December 14, 2001
Free information packages from the featured companies can be requested by sending an email to info@emergingcompany.com.
The television program can also be viewed online immediately at http://www.emergingcompany.com .
Featured companies this week include:
CEO Dr. James Namnath of Trinity Medical Group USA (OTC Bulletin Board: TMGU) detailed the Company's rights to market a patented HIV-Immunogen known as REMUNE(R). "REMUNE is based upon Dr. Jonas Salk's vaccine technology and is very different than current HIV drugs, which have shown significant side effects," he said. "It stimulates the body to defend itself against HIV infected cells and perhaps induces other agents that inhibit HIV."
ValCom, Inc. (OTC Bulletin Board: VACM) Director of PR Shari Edwards spoke of the company's production studios, which provide facilities for programs like CBS Television's hit series, "Jag." "The company has changed its fiscal year to coincide with that of the entertainment industry," she said.
E. Robert Gates, Ph.D., C.O.O. of ATNG, Inc. (OTC Bulletin Board: ATNG) spoke of the company's Blue Kiwi flat rate long distance calling plan for $34.95 monthly.
Semotus Solutions, Inc. (Amex: DLK) CEO Anthony Lapine reaffirmed his company's progress towards cash flow profitability in the coming months of the new year.
Viewers of Emerging Company Report can receive free information in the mail about featured companies by calling the toll-free phone number on their TV screen. The weekly television program debuted in 1996 and is seen nationally on Friday evenings at 11:00 ET, 8:00 PT, Saturdays at 4:00 PM ET, 1:00 PM PT and Sunday mornings at 11:00 ET, 8:00 PT. The program is broadcast to over 35 million cable TV homes weekly in more than 350 cities nationwide.
A complete menu of cable TV channels is available at the Emerging Company Report web site, http://www.emergingcompany.com .
Emerging Company Report television program, Copyright 2001, All Rights Reserved. Emerging Company Report does not provide an analysis of companies' financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks. Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst. Emerging Company Report has been paid a cash fee of $11,500.00 by the featured companies, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by the producers, publisher or parent company of Emerging Company Report.
011214
PR011222
Copyright © 2001 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.PRNewswire.com.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .